Yesterday1 event
Today20 events
To consider and approve the un-audited Financial Results of the Company (Standalone and Consolidated) for the quarter ending 31st March, 2026.
To consider and approve the annual audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026. Also, to consider and recommend final dividend and discuss matters relating to the ensuing Annual General Meeting.
To consider and approve the audited financial results for the quarter and financial year ending March 31, 2026. Also, to recommend a final dividend, if any.
To consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2026.
To consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Year ended March 31, 2026.
To consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board will also consider the proposal to recommend a final dividend.
The Board meeting is scheduled to consider and approve audited standalone and consolidated financial results for the quarter and financial year ending 31st March, 2026. It will also consider the recommendation of dividend.
06 May 20269 events
To consider and approve the unaudited and audited financial results for the fourth quarter and financial year ended March 31, 2026. The board will also consider the recommendation of a final dividend for the year.
To consider and approve the sale, transfer, and disposal of land pertaining to the closed Textile Plant of the Company.
To consider and approve audited financial results for the quarter and year ended March 31, 2026. The Board may also consider recommendation of final dividend.
To consider increasing the authorized share capital and approve a material related party transaction for revision in project cost.
To consider and approve the audited financial results for the quarter and financial year ended 31 March 2026.
To consider and approve financial results for the quarter and year ended March 31, 2026, declare distributions to unitholders, and raise debt.
To consider and approve Audited Financial Results for the 4th quarter and financial year ended March 31, 2026, and to consider and recommend Final Dividend, if any.
To consider and approve the Audited Financial Results for the Quarter and Financial Year ended March 31, 2026, and to consider recommending Dividend, if any.
To consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider the recommendation of dividend.
To consider and approve the unaudited (standalone & consolidated) financial results for the quarter and nine months ended 31st March, 2026.
To consider and approve standalone and consolidated audited financial results for the quarter and financial year ended March 31, 2026, and to consider recommendation of final dividend.
To take on record and approve the certificate issued by M/s. PAMS & Associates, Statutory Auditors, pursuant to Regulation 45(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.
To consider increasing the authorized share capital and altering the capital and object clauses of the Memorandum of Association.
To consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and financial year ending on March 31, 2026.
An Extra Ordinary General Meeting will be held to consider and pass a resolution to increase the authorised share capital of the company.
To consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026, and to recommend dividend on equity shares.